BN Business News
Add your company to Business Communicator →

Business · 19/11/20261 min read

Implantica publishes Interim Report January - September 2026 (Q3)

EDITORIAL ILLUSTRATIONBBusinessBN
Illustration generated by Business News; it is not a source photograph.

Summary

VADUZ, Liechtenstein, Nov. 19, 2026 — FDA approval secured and first U.S. patients treated at USC Significant events in the third quarter of 2026 FDA Premarket Approval (PMA) granted for RefluxStop® on August 20, opening the world's largest medical device market and enabling...

Original source language: PR Newswire — Global News ReleasesOpen original release →

Explore insights

Business insights →